# Xeris Biopharma Holdings, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/xeris-biopharma-holdings-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 9 |
| Claims under review | 1 |
| Evidence records | 6 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-11-16T18:06:00.495142+00:00 |
| Last reviewed | 2026-11-16T18:06:00.495142+00:00 |

## Identity

- Legal name: Xeris Biopharma Holdings, Inc.
- Display name: Xeris Biopharma Holdings, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-11-16T18:06:00.495142+00:00 |
| Completeness | 0.318 |
| Record Quality | 0.812 |
| Directors | 0 |
| Committees | 0 |
| Governance events | 5 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | NOT_REVIEWED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Executive leadership

- Anh T. Nguyen: Named Executive Officer. Status: current. claim_id=alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:5
- Beth Hecht: Named Executive Officer. Status: current. claim_id=alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:6
- John Shannon: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:7
- Kevin McCulloch: Named Executive Officer. Status: current. claim_id=alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:8
- Steven Pieper: Named Executive Officer. Status: current. claim_id=alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:9

## Governance events

- EXECUTIVE_APPOINTED: Anh T. Nguyen executive of Xeris Biopharma Holdings, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-11-16T18:06:00.495142+00:00. event_id=alpha:event:transition:1edo40qn3aqje
- EXECUTIVE_APPOINTED: Beth Hecht executive of Xeris Biopharma Holdings, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-11-16T18:06:00.495142+00:00. event_id=alpha:event:transition:oojmb31n3ofe7
- CEO_ROLE_RECORDED: John Shannon executive of Xeris Biopharma Holdings, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-11-16T18:06:00.495142+00:00. event_id=alpha:event:transition:1252w9n1frz343
- EXECUTIVE_APPOINTED: Kevin McCulloch executive of Xeris Biopharma Holdings, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-11-16T18:06:00.495142+00:00. event_id=alpha:event:transition:1jsdgeuxd1pwo
- EXECUTIVE_APPOINTED: Steven Pieper executive of Xeris Biopharma Holdings, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-11-16T18:06:00.495142+00:00. event_id=alpha:event:transition:l8r9zs19lqspu

## Scoped resources

- `alpha://company/xeris-biopharma-holdings-inc` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record
- `alpha://company/xeris-biopharma-holdings-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=identity
- `alpha://company/xeris-biopharma-holdings-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=corporate-structure
- `alpha://company/xeris-biopharma-holdings-inc/board` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=board
- `alpha://company/xeris-biopharma-holdings-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=committees
- `alpha://company/xeris-biopharma-holdings-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=leadership
- `alpha://company/xeris-biopharma-holdings-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=ownership
- `alpha://company/xeris-biopharma-holdings-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=financials
- `alpha://company/xeris-biopharma-holdings-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=capital-structure
- `alpha://company/xeris-biopharma-holdings-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=compensation
- `alpha://company/xeris-biopharma-holdings-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=governance
- `alpha://company/xeris-biopharma-holdings-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=shareholder-governance
- `alpha://company/xeris-biopharma-holdings-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=audit
- `alpha://company/xeris-biopharma-holdings-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=legal
- `alpha://company/xeris-biopharma-holdings-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=risk
- `alpha://company/xeris-biopharma-holdings-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=cyber
- `alpha://company/xeris-biopharma-holdings-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=ai-governance
- `alpha://company/xeris-biopharma-holdings-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=agents
- `alpha://company/xeris-biopharma-holdings-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=ecosystem
- `alpha://company/xeris-biopharma-holdings-inc/events` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=events
- `alpha://company/xeris-biopharma-holdings-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=relationships
- `alpha://company/xeris-biopharma-holdings-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=assessments
- `alpha://company/xeris-biopharma-holdings-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Anh T. Nguyen: Named Executive Officer. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:5. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b75aeee3afca2075f8ca05cd923508be00bb57a203562bdf30dda19afd3c5814.
- Beth Hecht: Named Executive Officer. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:6. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c83eb23ddd7d6e258bcbff0e273b5f8e21eaaa646542f4cfce8fa9732510c234.
- John Shannon: Chief Executive Officer. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:7. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0d6a514576e22fa5ff12e3d28689112b2fd08c255d4db9b99b68fd29e37c352d.
- Kevin McCulloch: Named Executive Officer. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:8. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9d905af6c19afca0d540f74977ca0554483f5078235198eae54f5e6df263aea9.
- Steven Pieper: Named Executive Officer. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:leadership_role:9. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:799422c1985e8ce9a2c94d9b0ab2204214b1cc8b57ca677578c051bf950f344f.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- NOT_ASSERTED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Xeris Biopharma Holdings, Inc.. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:63f36da7c568bf39732bb3b1e5298214d65514e2f74622f6f815903f297ed26f.

## Entity Status

- Public listing published. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:63f36da7c568bf39732bb3b1e5298214d65514e2f74622f6f815903f297ed26f.

## Published Fact

- US. Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:63f36da7c568bf39732bb3b1e5298214d65514e2f74622f6f815903f297ed26f.

## Security Listing

- XERS (NASDAQ). Claim: alpha:claim:company:a9a7bb01-38c7-4cbd-9127-7fa7adddc60d:security_listing:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:63f36da7c568bf39732bb3b1e5298214d65514e2f74622f6f815903f297ed26f.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | NOT_ASSERTED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:63f36da7c568bf39732bb3b1e5298214d65514e2f74622f6f815903f297ed26f: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc).
- alpha:projection-evidence:document:b75aeee3afca2075f8ca05cd923508be00bb57a203562bdf30dda19afd3c5814: [XERS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1867096/000186709626000021/xers-20260423.htm).
- alpha:projection-evidence:document:c83eb23ddd7d6e258bcbff0e273b5f8e21eaaa646542f4cfce8fa9732510c234: [XERS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1867096/000186709626000021/xers-20260423.htm).
- alpha:projection-evidence:document:0d6a514576e22fa5ff12e3d28689112b2fd08c255d4db9b99b68fd29e37c352d: [XERS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1867096/000186709626000021/xers-20260423.htm).
- alpha:projection-evidence:document:9d905af6c19afca0d540f74977ca0554483f5078235198eae54f5e6df263aea9: [XERS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1867096/000186709626000021/xers-20260423.htm).
- alpha:projection-evidence:document:799422c1985e8ce9a2c94d9b0ab2204214b1cc8b57ca677578c051bf950f344f: [XERS DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1867096/000186709626000021/xers-20260423.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/xeris-biopharma-holdings-inc)
- [Public Markdown](https://registry.alpha.ac/companies/xeris-biopharma-holdings-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/xeris-biopharma-holdings-inc?format=jsonld)
- MCP resource: `alpha://companies/xeris-biopharma-holdings-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-11-17T22:40:00.321901+00:00; recorded 2026-11-17T22:40:00.321901+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.